Drug
Glofitamab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Cytokine Release Syndrome | 747 | 359.2 | 522.7 | signal |
| 2 | Disease Progression | 444 | 33.3 | 40.6 | signal |
| 3 | Covid-19 Pneumonia | 29 | 21.5 | 21.8 | signal |
| 4 | Bacterial Infection | 34 | 16.1 | 16.4 | signal |
| 5 | Blood Lactate Dehydrogenase Increased | 29 | 16.0 | 16.2 | signal |
| 6 | Febrile Neutropenia | 103 | 13.7 | 14.3 | signal |
| 7 | Neutropenia | 185 | 12.0 | 13.0 | signal |
| 8 | Hepatic Cytolysis | 16 | 11.5 | 11.6 | signal |
| 9 | Acute Myeloid Leukaemia | 19 | 10.7 | 10.8 | signal |
| 10 | Cytopenia | 13 | 9.6 | 9.6 | signal |
| 11 | Alanine Aminotransferase Increased | 60 | 8.6 | 8.8 | signal |
| 12 | Septic Shock | 40 | 8.2 | 8.3 | signal |
| 13 | Aspartate Aminotransferase Increased | 48 | 8.0 | 8.1 | signal |
| 14 | Myelosuppression | 28 | 7.2 | 7.3 | signal |
| 15 | Intestinal Perforation | 9 | 7.1 | 7.1 | signal |
| 16 | Pneumocystis Jirovecii Pneumonia | 8 | 7.0 | 7.1 | signal |
| 17 | Blood Bilirubin Increased | 21 | 6.8 | 6.9 | signal |
| 18 | Neoplasm Progression | 26 | 6.5 | 6.6 | signal |
| 19 | Sinus Tachycardia | 10 | 6.2 | 6.2 | signal |
| 20 | Neoplasm | 8 | 6.1 | 6.1 | signal |
| 21 | Infection | 99 | 6.0 | 6.3 | signal |
| 22 | Thrombocytopenia | 76 | 6.0 | 6.2 | signal |
| 23 | Covid-19 | 115 | 5.7 | 6.0 | signal |
| 24 | Hypercalcaemia | 8 | 5.7 | 5.7 | signal |
| 25 | Immune System Disorder | 8 | 5.4 | 5.4 | signal |
| 26 | Cytomegalovirus Infection | 10 | 5.3 | 5.3 | signal |
| 27 | Pneumonitis | 16 | 5.2 | 5.2 | signal |
| 28 | Temperature Intolerance | 6 | 5.2 | 5.2 | signal |
| 29 | Neurotoxicity | 10 | 5.1 | 5.1 | signal |
| 30 | Metastases To Liver | 10 | 5.0 | 5.0 | signal |
| 31 | Lymphocyte Count Decreased | 10 | 5.0 | 5.0 | signal |
| 32 | Neutrophil Count Decreased | 22 | 4.8 | 4.8 | signal |
| 33 | Therapy Partial Responder | 8 | 4.7 | 4.7 | signal |
| 34 | Shock | 12 | 4.6 | 4.6 | signal |
| 35 | Tachypnoea | 7 | 4.5 | 4.6 | signal |
| 36 | Lymphoma | 8 | 4.5 | 4.6 | signal |
| 37 | Fungal Infection | 17 | 4.5 | 4.5 | signal |
| 38 | Viral Infection | 16 | 4.2 | 4.3 | signal |
| 39 | Platelet Count Decreased | 46 | 3.8 | 3.9 | signal |
| 40 | Lymphopenia | 6 | 3.8 | 3.8 | signal |
| 41 | Malignant Neoplasm Progression | 38 | 3.3 | 3.3 | signal |
| 42 | Metastases To Bone | 6 | 3.2 | 3.2 | signal |
| 43 | Mucosal Inflammation | 9 | 3.0 | 3.0 | signal |
| 44 | Peritonitis | 7 | 3.0 | 3.0 | signal |
| 45 | Polyneuropathy | 4 | 3.0 | 3.0 | no signal |
| 46 | Death | 282 | 2.9 | 3.1 | signal |
| 47 | No Adverse Event | 57 | 2.8 | 2.9 | signal |
| 48 | Myelodysplastic Syndrome | 4 | 2.4 | 2.4 | no signal |